Stay updated on BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial

Sign up to get notified when there's something new on the BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Publication note in the PubMed section was updated to say publications are automatically filled in from PubMed. The page revision is updated to v3.3.2 (replacing v3.2.0).
    Difference
    0.1%
    Check dated 2025-11-26T08:39:03.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A temporary government funding status notice was removed. The page's study details, eligibility criteria, and outcome measures remain unchanged.
    Difference
    0.2%
    Check dated 2025-11-19T08:09:48.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    No significant changes detected; core study details and endpoints appear unchanged.
    Difference
    0.3%
    Check dated 2025-10-28T02:41:04.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    New content adds Paratus Clinical Research Woden and an updated data-sharing scope for Boehringer Ingelheim studies; older, more specific IPD sharing details and access criteria from 2022-era text have been removed.
    Difference
    8%
    Check dated 2025-10-21T01:21:24.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Added a government-operation status notice and link details plus a version bump to v3.2.0; removed the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-06T15:48:56.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    - Updated version to v3.1.0 and added the term Palmoplantar pustulosis; removed several older or broader drug-safety/quality terms (e.g., Drug Safety, Counterfeit Drugs, Substandard Drugs, Pharmaceutical Preparations, Pustulosis palmaris et plantaris).
    Difference
    0.4%
    Check dated 2025-09-29T09:46:25.000Z thumbnail image

Stay in the know with updates to BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial page.